Rankings
▼
Calendar
BCRX Q2 2016 Earnings — BioCryst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
BCRX
BioCryst Pharmaceuticals, Inc.
$2B
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
Gross Profit
$5M
99.4% margin
Operating Income
-$12M
-253.4% margin
Net Income
-$16M
-340.1% margin
EPS (Diluted)
$-0.22
QoQ Revenue Growth
-0.7%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$13M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$82M
Total Liabilities
$69M
Stockholders' Equity
$13M
Cash & Equivalents
$9M
← FY 2016
All Quarters
Q3 2016 →
